 |
Kanwar
Saini , MD
The patient is a 39-year-old Haitian
man brought to Albany Medical Center from jail for progressive muscle
weakness and recurrent facial edema, especially prominent in lips
and eyelids. The edema started about 2-3 months ago and progressively
worsened to the point that the patient was unable to open his mouth
or his eyes. He experienced difficulty swallowing solids as well
as liquids on and off for about the same time and had also developed
a rash on his upper torso and back, and the extensor surfaces of
all four extremities. The patient complained of generalized muscle
weakness that had been present for a few years but had now progressed
to the point that he was unable to rise from a chair, ascend the
stairs or even brush his teeth.
A month prior to admission, he was
seen by a doctor at the correctional facility and was started on
prednisone 50mg QD. The steroids were tapered, and his symptoms,
which had improved, returned once he reached a dose of 5mg QD.
Past medical history and surgical
history are unremarkable, and the patient denied the use of any
tobacco or recreational drugs, but prior to incarceration, drank
"a few beers" on weekends. He had worked as a cab driver
in NYC. Medications at the time of admission included only prednisone
5mg QD. In review of systems, the patient denied any nausea, vomiting,
trauma, abdominal pain, fever or recent infections. He admitted
to losing about 20 pounds in the 2 months prior to admission, with
accompanying decrease in appetite and dysphagia. As stated above,
he also had muscle weakness and a rash. He denied any previous episodes
similar to this, and reported no family history of musculoskeletal
disease.
On physical examination, his temperature
was 97.3 degrees, blood pressure 112/70, pulse 100, respirations
20, and oxygen saturation 100% in room air. In general, the patient
was a thin Haitian male lying in bed in mild distress with marked
facial edema. His head was normocepahalic atraumatic. His pupils
were equal, round, reactive, and accommodating to light. His extra
ocular muscles were intact. He had marked swelling of his periorbital
region with dry oral mucosa. His neck was supple without jugular
venous distention, bruits or lymphadenopathy. His heart had a regular
rate and rhythm without murmur. Lungs were clear to ausculate without
wheezing or rales. His abdomen was soft with positive bowel sounds.
His skin had purple and pinkish confluent, flat rash around his
eyes with areas of hyperpigmentation. The rash was also present
on his upper torso, back, knees, and elbows. He was alert and oriented
to person, place and time, but unable to speak articulately secondary
to his facial edema and weakness. Cranial nerves were grossly intact.
His strength was 3/5 in bilateral hip flexors and 3/5 in bilateral
shoulder abductors, with normal reflexes.
On admission, laboratory values included
sodium 134, chloride 98, potassium 5.5, bicarbonate 27, BUN 26,
creatinine 0.8, and glucose 113. His albumin 2.5, ALP 49, AST 308,
ALT 76, INR 0.9, PTT 29.7, ESR 82, and ANA positive. His CPK 6670,
MB fraction 27.3, (0.4%), LDH 363, and Calcium 8.8. He had a normal
thyroid function test and was negative for serum Hepatitis A, B
and C and HIV screens. His urine and blood cultures were negative.
Chest X-ray was unremarkable and EKG had no ST changes.
During the course of his hospital
stay the rheumatology service was consulted. They recommended EMG,
Nerve conduction studies, and muscle biopsy for further evaluation
and definitive diagnosis. EMG and Nerve conduction studies were
consistent with myositis. Muscle biopsy from the patients
proximal quadriceps showed perivascular lymphohistiocytic inflammation,
which was non-diagnostic, but raised the possibility of inflammatory
myopathy. At admission, the patient was started on Solumedrol 40
mg IV BID and then switched to Prednisone 40 mg BID. He was also
started on Methotrexate 20 mg SQ once a week with folic acid supplements.
The patients symptoms improved remarkably. His muscle strength
improved and he was able to participate in physical therapy. His
periorbital swelling decreased, but he was still not tolerating
oral intake, so a Video Esophagram was ordered and showed marked
aspiration due to poor control of the upper airway as well pharyngeal
muscle weakness. A Gastro-Jejunumostomy (G-J) tube was therefore
recommended for long term feeding and to prevent aspiration. He
received a G-J tube and tolerated tube feeds well. An EGD and colonoscopy
were performed and were unremarkable. The patient was discharged
back to his facility with prednisone, methotrexate, and a G-J tube
with an outpatient follow up with Rheumatology.
DISCUSSION
This patient was diagnosed with dermatomyositis.
His symptoms and signs fit all the diagnostic criteria and demonstrated
a classical presentation. Idiopathic inflammatory muscle disease
is typically associated with proximal muscle weakness, muscle enzyme
elevations (CPK, LDH), characteristic EMG, inflammatory infiltrations
on muscle biopsy and skin rash. If no rash is present, diagnosis
is consistent with polymyositis, and if rash is present, a diagnosis
of dermatomyositis can be made. Our patient exhibited elevated muscle
enzymes, characteristic EMG with spontaneous fibrillation, and muscle
biopsy consistent with inflammatory myopathy.
Dermatomyositis usually occurs in
1/200,000 people and peaks in childhood or late adulthood. It is
twice as common in women. The etiology of the disease is unknown,
but it is believed to be initiated by viral infection and altered
immune response. Lymphocyte mediated muscle cell damage and small
vessel damage are important central pathogenetic factors. Usually
vascular deposits of immune complexes and complement are associated
with endothelial cell injury and small vessel obstruction. Dermatomyositis
is usually associated with CD4 T cells and B cells infiltrating
the muscles whereas polymyositis is associated with CD8 cytotoxic
T cells. Other features of dermatomyositis includes a heliotrope
rash, which is a violet discoloration and swelling of the eyelids,
erythematous papules over MCP and PIP joints, called Gottrons
sign, and erythematous skin and hypertrophic changes of palms and
fingers, called Mechanics hands. This disease process has
a gradual and steady progression of symmetrical skeletal muscle
weakness of proximal, upper, and lower extremities. The patients
are also prone to congestive heart failure, arrhythmias, chronic
interstitial lung disease, aspiration pneumonitis and inflammatory
arthritis. Autoantibodies are present in 80-90% of the patients,
the most common being ANA, but RO Ab, LA Ab, Synthetase Ab, Jo-1
Ab, SRP Ab are also seen. Risk of malignancy is increased by 10-25
% with dermatomyositis as compared with polymyositis, especially
cancers of the lung, gastrointestinal tract, breast, uterus, and
ovaries. Treatment is usually with high dose corticosteroids and
immunosuppressive agents such as methotrexate, azathioprine and
cyclosporine. Physical therapy is essential to prevent contractures.
For steroid resistant patients, IV immunoglobulin can be used.
The differential diagnosis includes
hyperthyroidism, which has normal CPK levels, hypothyroidism, which
may demonstrate proximal muscle weakness, elevated CPK, but abnormal
thyroid function tests, and Cushing syndrome, which can cause proximal
muscle weakness but has normal enzymes. Drugs like cholesterol-lowering
drugs, corticosteroids, AZT, and colchicine can also cause muscle
weakness. Other muscle diseases like muscular dystrophies and metabolic
muscle diseases usually have a family history associated with them.
Some neurological diseases can also present with muscle weakness,
for example: myasthenia gravis, amyotrophic lateral sclerosis, multiple
sclerosis, but also have other neurological deficits associated
with them. Other diseases that can present with muscle weakness
include Lyme disease, HIV, toxplasmosis, influenza, and vasculities
such as SLE, rheumatoid arthritis, progressive systemic sclerosis
and Sjogrens syndrome. Sarcoidosis can also have inflammatory
muscle involvement, but biopsy usually shows non-caseating granuloma,
increased ACE levels and chest x-ray showing bilateral hilar adenopathy.
References
- Lawrence, Tierney, MD et al. Current Medical Diagnosis
39th ed. 2000: p 838-841.
- Shubhada N. Ahya, MD et al. The Washington Manual
of Medical Therapeutics. 30th ed. 2001: p 514-515.
- Chow, WH, Gridley et al. Cancer risk following polymyositis
and dermatomyositis: A nationwide cohort study in Denmark.
1995; 6-10.
|